Raymond James Financial Services Advisors’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-15,180	Closed	-$508K	–	3312
2021 Q2	$508K	Sell	15,180 -71	-0.5%	-$1.95K	﹤0.01%	2356
2021 Q1	$314K	Buy	15,251 +71	+0.5%	+$1.63K	﹤0.01%	2595
2020 Q4	$266K	Sell	15,180 -20	-0.1%	-$360	﹤0.01%	2536
2020 Q3	$225K	Sell	15,200 -200	-1%	-$2.34K	﹤0.01%	2464
2020 Q2	$200K	Sell	15,400 -1,586	-9%	-$7.03K	﹤0.01%	2496
2020 Q1	$28K	Buy	16,986 +46	+0.3%	+$104	﹤0.01%	2349
2019 Q4	$38K	Hold	16,940	–	–	﹤0.01%	2779
2019 Q3	$36K	Hold	16,940	–	–	﹤0.01%	2721
2019 Q2	$45K	Buy	+16,940	New	+$57.5K	﹤0.01%	2751
2019 Q1	–	Sell	-1,942	Closed	-$6K	–	2812
2018 Q4	$6K	Sell	1,942 -5	-0.3%	-$25	﹤0.01%	2550
2018 Q3	$13K	Buy	1,947 +155	+9%	+$1.08K	﹤0.01%	2781
2018 Q2	$14K	Sell	1,792 -67	-4%	-$896	﹤0.01%	2738
2018 Q1	$65K	Hold	1,859	–	–	﹤0.01%	2426
2017 Q4	$79K	Buy	1,859 +67	+4%	+$2.87K	﹤0.01%	2399
2017 Q3	$77K	Hold	1,792	–	–	﹤0.01%	2419
2017 Q2	$66K	Sell	1,792 -134	-7%	-$5.93K	﹤0.01%	2383
2017 Q1	$104K	Buy	1,926 +400	+26%	+$20.8K	﹤0.01%	2258
2016 Q4	$81K	Sell	1,526 -347	-19%	-$19.7K	﹤0.01%	2209
2016 Q3	$114K	Buy	1,873 +656	+54%	+$40.9K	﹤0.01%	2137
2016 Q2	$80K	Buy	+1,217	New	+$77.3K	﹤0.01%	2127

Other funds holding CLDX